Deepika Malik
Retina Specialist · Woodbury, NYNPI 1134530306
Payments from drug & device makers
Across 421 payments — averaging $526.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$65K
- Genentech USA, Inc.$58K
- Biogen$33K
- Alimera Sciences, Inc.$29K
- AbbVie$8K
- Regeneron$7K
- plus $22K from 19 others
Across 2 payments — averaging $349.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$698
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 73 | $64,657 |
| Genentech USA, Inc. | 96 | $58,434 |
| Biogen | 30 | $33,107 |
| Alimera Sciences, Inc. | 49 | $28,730 |
| AbbVie(2 entities) | 34 | $8,145 |
| Regeneron | 10 | $6,771 |
| Genentech, Inc. | 7 | $6,687 |
| Bausch & Lomb Americas Inc. | 17 | $5,525 |
| Apellis Pharmaceuticals, Inc. | 16 | $2,591 |
| Neurotech Pharmaceuticals, Inc. | 3 | $2,094 |
| Eyepoint US, Inc. | 2 | $1,615 |
| Mallinckrodt Hospital Products Inc. | 15 | $622 |
| Alcon | 9 | $539 |
| ANI Pharmaceuticals, Inc. | 19 | $508 |
| Novartis | 4 | $469 |
| Astellas Pharma US Inc | 8 | $233 |
| Harrow Eye, LLC | 9 | $226 |
| Dompe US, Inc. | 4 | $209 |
| Glaukos Corporation | 1 | $161 |
| Oyster Point Pharma, Inc. | 8 | $154 |
| Spark Therapeutics, Inc. | 1 | $125 |
| Tarsus Pharmaceuticals, Inc. | 3 | $67 |
| Biotissue Holdings Inc. | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Sight Sciences, Inc. | 1 | $18 |
How this compares
$221,736 in reported general payments places this provider in the 90th percentile of 99 retina specialist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Woodbury
- Jamin BrownLiverpool$3.3M
- Brian ConnollyRochester$1.7M
- Paul HahnNanuet$1.1M
- Patrick OellersLiverpool$615K
- Naomi FalkSlingerlands$436K
- Edward HallRochester$264K
- Matthew WitmerRochester$246K
- Szilard KissNew York$222K
- Ferhina AliValhalla$176K
- Steven RoseRochester$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.